期刊文献+

弥漫大B细胞淋巴瘤细胞免疫状态与国际预后指数的关系 被引量:11

Relationship between the international prognosis indexes and the cell-mediated immunity condition in DLBCL patients
原文传递
导出
摘要 目的探讨弥漫大B细胞淋巴瘤(DLBCL)患者细胞免疫状态与国际预后指数(IPI)的关系。方法初治DLBCL患者52例,按照IPI积分分为4组(低危组17例、低中危组16例、中高危组12例、高危组7例),采用流式细胞术检测各DLBCL组与健康对照组(43例)T淋巴细胞亚群(包括CD3、CD3C4、CD3CD8)、NK细胞的绝对计数值及CD;/CD],各组间比较并分析IPI的5个指标与各T淋巴细胞亚群绝对值的相关陆。结果DLBCL高危组的CD3细胞(1570.9±370.5)个/μl,较其他IPI组高;DLBCL4组的CD4细胞数均低于健康对照组的(751.3±367.4)个/μl;DLBCL高危组的cD;细胞(1055.9±523.8)个/μl,较健康对照组及其他IPl分组明显升高;中高危组与高危组的CD]/CD;LL值(1.0±0.2、0.7±1.0)降低明显,与健康对照组、低危组、低中危组比较差异均有统计学意义(P〈0.05);中高危组与高危组NK细胞较健康对照组明显降低[(199.5±68.4)/m、(171.9±126.9)/μl]。淋巴瘤患者的年龄、临床分期、全身状态与患者外周血T淋巴细胞亚群中的CD;细胞数、CD8细胞数以及CD4/CD8 比值有相关性。结论初治的DLBCL患者细胞免疫状态与1PI有关;随着IPI积分的增加,DLBCL患者免疫抑制与紊乱加重,NK细胞功能越差,预后也更差。 Objective To explore the relationship between the international prognosis indexes(IPI) and the cell-mediated immunity condition in DLBCL patients. Methods 52 DLBCL patients were divided into 4 groups and the FCM was used to examine the T lymphocyte subsets, including CD3,CD4,CD8 NK cells . T lymphocyte subsets absolute value and CD4/CD8 ratio were examined. Correlation with IPI were compared among groups. Results CD; cells in high risk group [(1570.9±370.5)/μl]were higher than other IPI groups; CD4 cells in DLBCL groups were all lower than normal group(751.3±367.4)/μl]; CD8 cells in high risk group [( 1055.9±523.8)/μ1] were higher than other groups; CD4/CD8 ratio in middle-high risk group and high risk group (1.0±0.2,0.7±1.0) were lower than other IPI groups and normal group; NK cells in middle-high risk group and high risk group were lower than the normal group [(199.5±68.4)/μl,(171.9±126.9)/μl]; Age, clinical stage,body state had correlated with the CD3 ,CD4 cells and CD4/CD8 ratio of the DLBCL patients' peripheral blood T lymphosyte subsets. Conclusions The immunity condition in DLBCL patients has correlated with IPI; With increasing IPI value, the immunity depression and disorder become more serious, NK cells function become worse, and the prognosis is bad too.
出处 《白血病.淋巴瘤》 CAS 2012年第5期285-287,共3页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 大细胞 弥漫性 免疫 细胞 T淋巴细胞亚群 杀伤细胞 天然 国际预后指数 Lymphoma, large cell, diffuse Immunity, cellular T lymphocyte subsets Killer cells, natural International prognosis index
  • 相关文献

参考文献13

二级参考文献44

  • 1刘陶文,陈煌基.肿瘤相关物质群(TSGF)联合检测的临床应用研究[J].华夏医学,2004,17(3):293-297. 被引量:8
  • 2郭亚军,吴孟超,刘广洛,孔宪涛,张鲁榕,祝念林.原发性肝细胞癌患者外周血T细胞亚群、自然杀伤细胞、抗体依赖细胞毒效应改变及其临床意义[J].上海医学,1989,12(3):139-143. 被引量:7
  • 3周信达,汤钊猷,余业勤,杨秉辉,张博恒.影响肝癌预后的有关因素分析[J].中华内科杂志,1996,35(8):527-529. 被引量:18
  • 4Neglia F, Orengo AM, Cilli Met al. DNA vaccination against the ovari- an cancinoma - associated antigen folate receptor alpha (Fralpha) inducescytotoxic T lymphocyte and antibody responses in mice. Cancer Gene Ther, 1999, 6:349.
  • 5Vanderkwaak TJ, Alvarez R. Immune directed therapy for ovarian carcinoma. Curr Opin Obstet Gynecol , 1999, 11 : 29.
  • 6Fernadez Cruz. Elimination of syngeneie sarcomas in rats by a subset of T lymphocytes. JExp Med, 1980, 152:82.
  • 7Katsumoto Y, Monden T , Takoda T et al. Analysis of cytotoxic active ofthe CD4 + T lymphocytes generated by local immunotherapy. Br JCancer, 1996, 73:110.
  • 8Schroder W , Vering A, Stegmuller M et al. Lymphocyte subsetsin patients with Ovarian and breast cancer. Eur J Gynaecol Oneol, 1997, 18 (6) : 474.
  • 9Nelson BH. The impact of T - cell immunity on ovarian cancer outcomes. Immunol Rev, 2008, 222 ( 1 ) : 101.
  • 10Gause WG, Ekkens M, Nguyen D, et al. The development of CD4^+ T effector cells during the type 2 immune response. Immunol Res, 1999, 20: 55-65.

共引文献86

同被引文献94

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部